Literature DB >> 11041547

Ca2+ and electrolyte mobilization following agonist application to the pancreatic beta cell line HIT.

I Nakagaki1, S Sasaki, S Hori, H Kondo.   

Abstract

We have investigated intracellular Ca2+ mobilization in oscillations of cytoplasmic Ca2+ in response to glucagon-like peptide 1 (GLP-1) and glucose in clonal HIT insulinoma cells with a confocal laser-scanning microscope (CLSM). We also used electron probe X-ray microanalysis to determine the GLP-1- and glucose-induced changes in electrolyte levels in the cytoplasm and insulin granules of the cells. GLP-1 produced 10- to 35-s duration oscillations in cytoplasmic Ca2+ concentration ([Ca2+]i), both with and without Ca2+ in the extracellular solution, suggesting that Ca2+ is mobilized from intracellular Ca2+ stores, namely secretory granules. Glucose caused 1- to 3-min duration oscillatory increases in [Ca2+]i when the extracellular solution contained Ca2+. When the cells were cultured without Ca2+ (no Ca2+ added, 1 mM EGTA), an oscillatory [Ca2+]i increase of amplitude and short duration (12-35 s) was produced by 11 mM glucose, and the oscillation was inhibited by ruthenium red. X-ray microanalysis showed that stimulation with glucose increased the total Ca concentration in the cytoplasm and decreased it in the insulin granules with and without Ca2+ in the extracellular solution. The application of glucose significantly decreased K, and increased Na and C1 in the cytoplasm when the extracellular solution contained Ca2+. Our result also suggests that the [Ca2+]i oscillation induced by glucose is involved in the release of Ca2+ from intracellular Ca2+ stores through the ryanodine receptor, which is blocked by ruthenium red, and/or through the inositol trisphosphate receptor that may be present in the membrane of insulin granules.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11041547     DOI: 10.1007/s004240000372

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  8 in total

1.  Epac activates the small G proteins Rap1 and Rab3A to achieve exocytosis.

Authors:  María T Branham; Matías A Bustos; Gerardo A De Blas; Holger Rehmann; Valeria E P Zarelli; Claudia L Treviño; Alberto Darszon; Luis S Mayorga; Claudia N Tomes
Journal:  J Biol Chem       Date:  2009-06-22       Impact factor: 5.157

2.  New insights concerning the glucose-dependent insulin secretagogue action of glucagon-like peptide-1 in pancreatic beta-cells.

Authors:  G G Holz; G Holz
Journal:  Horm Metab Res       Date:  2004 Nov-Dec       Impact factor: 2.936

3.  cAMP-regulated guanine nucleotide exchange factor II (Epac2) mediates Ca2+-induced Ca2+ release in INS-1 pancreatic beta-cells.

Authors:  G Kang; O G Chepurny; G G Holz
Journal:  J Physiol       Date:  2001-10-15       Impact factor: 5.182

4.  Amplification of exocytosis by Ca2+-induced Ca2+ release in INS-1 pancreatic beta cells.

Authors:  Guoxin Kang; George G Holz
Journal:  J Physiol       Date:  2003-01-01       Impact factor: 5.182

5.  Glucagon-like peptide-1 mobilizes intracellular Ca2+ and stimulates mitochondrial ATP synthesis in pancreatic MIN6 beta-cells.

Authors:  Takashi Tsuboi; Gabriela da Silva Xavier; George G Holz; Laurence S Jouaville; Andrew P Thomas; Guy A Rutter
Journal:  Biochem J       Date:  2003-01-15       Impact factor: 3.857

Review 6.  GLP-1 receptor activated insulin secretion from pancreatic β-cells: mechanism and glucose dependence.

Authors:  A R Meloni; M B DeYoung; C Lowe; D G Parkes
Journal:  Diabetes Obes Metab       Date:  2012-08-01       Impact factor: 6.577

7.  Glucose-Dependent Insulin Secretion in Pancreatic β-Cell Islets from Male Rats Requires Ca2+ Release via ROS-Stimulated Ryanodine Receptors.

Authors:  Paola Llanos; Ariel Contreras-Ferrat; Genaro Barrientos; Marco Valencia; David Mears; Cecilia Hidalgo
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

8.  Simvastatin Impairs Insulin Secretion by Multiple Mechanisms in MIN6 Cells.

Authors:  Nagendra Yaluri; Shalem Modi; Maykel López Rodríguez; Alena Stančáková; Johanna Kuusisto; Tarja Kokkola; Markku Laakso
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.